Bayer Unveils Indian Joint Venture with Zydus Cadila

Bayer Zydus Pharma will focus on women's healthcare, diagnostic imaging, general medecines and oncology.

Chemical and pharmaceutical group Bayer said on Jan. 28 that it would create a joint venture in India with Zydus Cadila to enhance its presence in that country's fast growing market.

Bayer Zydus Pharma will focus on women's healthcare, diagnostic imaging, general medecines and oncology, a Bayer statement said.

"With this step, we aim to significantly accelerate our capabilities to better serve the fast growing Indian market," it quoted Joerg Reinhardt, chief executive of Bayer's HealthCare unit, as saying.

The new company is expected to have staff of 600, drawn from the parent groups, but financial details were not provided.

Copyright Agence France-Presse, 2011

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish